丹麦全国研究:2005-2018年老年与年轻上皮性卵巢癌患者的发病率、治疗与生存趋势
该研究纳入丹麦2005-2018年全国7522例上皮性卵巢癌患者,按年龄(<70岁和≥70岁)、分期和时期分析发病率、手术模式和癌症特异性生存变化。结果显示发病率下降,初次减瘤术比例降低而中间减瘤术和无减瘤术比例增加,无残留病灶比例和生存率均提高,但校正混杂因素后≥70岁仍与癌症特异性死亡风险增加1.4倍相关。
要点
- 发病率从2005年16.3降至2018年11.4/10万女性年,主要由年轻队列驱动。
- 2014-18年年轻和老年患者PDS比例分别为36%和24%,较2005-09年的72%和62%显著下降。
- 两年龄组无残留病灶比例和2年癌症特异性生存均显著提高,但老年患者生存仍较差。
核心结论
- 晚期EOC未行PDS或IDS的比例显著增加,同期无残留病灶比例和癌症特异性生存提高,但校正混杂因素后老年患者生存差距仍存在。
研究设计与样本
- 全国性队列研究,纳入丹麦2005-2018年诊断的7522例上皮性卵巢癌患者,按年龄(<70岁和≥70岁)、分期和时期(2005-09、2010-13、2014-18)分层分析。
主要发现
- 发病率从2005年16.3/10万女性年降至2018年11.4/10万女性年,下降由年轻队列驱动。
- IIIC-IV期患者中行PDS比例下降,行IDS和无减瘤术比例显著增加;2014-18年年轻和老年患者PDS比例分别为36%和24%,2005-09年分别为72%和62%。
- 两年龄组中IIIC-IV期患者及总队列的无残留病灶比例均显著增加。
- 2年癌症特异性生存:年轻患者从2005-09年75%升至2014-18年84%,老年患者从53%升至66%。
- 校正潜在混杂因素后,年龄≥70岁与癌症特异性死亡风险增加1.4倍相关(95%CI 1.2-1.5)。
临床怎么用
- 晚期EOC手术模式向IDS和无减瘤术倾斜,但无残留病灶比例提高,提示应关注手术时机和减瘤彻底性。
- 老年患者生存改善但仍存在差距,临床决策需综合考虑年龄因素并优化老年患者治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine clinical trends in Denmark for younger and older epithelial ovarian cancer (EOC) patients, focusing on incidence, treatment, and survival changes. METHODS: We included a nationwide cohort diagnosed with EOC from 2005 to 2018. We described age-standardized incidence, surgical patterns, residual disease trends, and cancer-specific survival stratified by age (<70 and ≥ 70 years), stage, and period (2005-09, 2010-13, 2014-18). RESULTS: We included 7522 patients. The incidence decreased from 16.3 (2005) to 11.4 (2018) per 100,000 woman-years, driven by the younger cohort. While the proportion of patients with stage IIIC-IV disease undergoing primary debulking surgery (PDS) decreased, the proportion of patients having interval debulking surgery (IDS) and no debulking surgery increased significantly. In 2014-18, 36% and 24% had PDS for younger and older patients, respectively, compared to 72% and 62% in 2005-09. In both age cohorts, the proportion of patients debulked to no residual disease increased significantly among patients with stage IIIC-IV and in the total cohort. Two-year cancer-specific survival increased from 75% (2005-09) to 84% (2014-18) for younger patients and from 53% to 66% for older patients. After adjusting for potential confounders, age ≥ 70 was associated with a 1.4-fold increased risk of cancer-specific death (95% confidence interval: 1.2,1.5). CONCLUSIONS: The proportion of patients with advanced EOC not undergoing PDS or IDS increased significantly. During the same period, patients debulked to no residual disease, and cancer-specific survival increased. However, a survival gap in favor of the younger patients remains after adjusting for potential confounders.
引用
- Ekmann-Gade AW, Høgdall CK, Seibæk L, et al. Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study. Gynecol Oncol. 2021. PMID: 34716025. doi:10.1016/j.ygyno.2021.10.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。